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The  DNA  binding properties of  ABFZ, an abundant 
protein  found in the  mitochondria  of  the  yeast Saccha- 
romyces cerevisiae have been examined in detail. 
ABFZ is closely related  to  the  vertebrate high mobility 
group  protein HMGl and like HMG1,  ABFZ will intro- 
duce negative supercoils into a relaxed, double- 
stranded  circular DNA molecule in cooperation with a 
DNA  topoisomerase.  Additionally, ABFZ binds ap- 
proximately 6-10 times more tightly to negatively 
supercoiled DNA than to relaxed circular or linear 
DNA. Although ABFZ binds  to  most  random  double- 
stranded sequences with roughly equal affinity, its 
binding within certain key regulatory regions is qual- 
itatively quite different. First, ABFZ binding  induces 
a distinct  pattern  of DNA bending within the  chromo- 
somal  origin  of DNA replication, ARSl. Second, ABFB 
binding to all nuclear replication origins tested, in 
addition  to  a critical mitochondrial  promoter  and  rep- 
lication origin, is clearly nonrandom as visualized  by 
DNase1 footprinting.  Analysis  of  the  sequences  found 
within these regions as well as competition experi- 
ments  with  synthetic DNA molecules  suggest  that site- 
specific DNA binding may be accomplished by the 
phased distribution of short stretches of poly(dA), 
which  exclude ABFZ binding.  These  patterns  of ABFB 
DNA  binding  suggest  a role for the  protein in genome 
organization  and site-specific regulation  of  transcrip- 
tion or DNA replication. 
Virtually all large genomic DNA molecules are found asso- 
ciated with a diverse group of abundant, basic, low molecular 
weight, DNA binding proteins whose primary  function is  to 
compact these DNA molecules and  to neutralize their negative 
charge, allowing them to fit into relatively small volumes. 
The elemental packaging unit in eucaryotic nuclei is the 
nucleosome octamer, composed of two copies each of the four 
core histones H2A, H2B, H3, and  H4 linked into higher order 
structures by the fifth histone, H1 (1). In addition to the 
histones, other  abundant chromosomal proteins known as  the 
high mobility group (HMG)’  proteins are found, although the 
roles of these proteins is less clear (2). In procaryotes, the 
prototypical packaging protein is the Escherichia coli HU 
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protein, which binds to DNA as a dimer. Additionally, several 
other, less well characterized, proteins  appear to be involved 
(3,4). 
The proteins that package the genomic DNA of eucaryotic 
organelles have been less well characterized. Recently, we 
described ABF2, a  protein  found in  the mitochondria of the 
yeast Saccharomyces cereukiae (5). The nuclear encoded 
ABF2 gene was cloned and shown to be required for the 
efficient maintenance of the mitochondrial genome. This, 
taken with the abundance of ABFZ (roughly one copy for 
every 15-30 bp of mitochondrial DNA) argued that ABF2 is 
involved in packaging the yeast mitochondrial genome. Re- 
markably, the predicted amino acid sequence of ABFZ is 
closely related to  the vertebrate nuclear high mobility group 
protein HMG1. Since mitochondria are widely believed to 
have descended from eubacteria via endosymbiosis (6,7), this 
suggests that  the packaging function of a primordial HU- 
related  protein was, at  some point during evolution, usurped 
by a nuclear-encoded HMGl protein.  Such an event may have 
been critical in ultimately establishing the control of the 
nuclear genome over the mitochondrial genome. 
The packaging of DNA poses a general problem: How can 
the accessibility of key regulatory DNA sequences within the 
genome to specific trans-acting  factors be guaranteed  against 
the overwhelming backdrop of nonspecific DNA binding by 
the packaging proteins? In  this report, we show that ABFS 
appears to bind to DNA by wrapping and, therefore, appears 
capable of compacting DNA. Furthermore, although ABFS 
binds to most DNA sequences with similar  affinity, its binding 
to key regulatory sequences from both the nucleus and  the 
mitochondria is strongly phased. We propose that such phased 
binding could provide access for other trans-acting factors 
involved in DNA replication and gene expression. 
Interestingly, a mitochondrial protein that is related to 
ABFS was recently identified as  the mitochondrial transcrip- 
tional  activator  protein mtTFl from human cells (8) and a 
related transcriptional activator has been identified in S. 
cereukiue (9). Indeed, it is probable that ABF2 is the S. 
cerevisiue mtTFl protein. Consistent with this possibility, 
Fisher et al. (10) report in the accompanying paper that 
mtTFl from both  human and yeast mitochondria has DNA 
binding properties  similar to those  reported herein for ABF2. 
MATERIALS AND METHODS 
Plnsmids and Strains-ABFP was purified from the yeast strains 
BJ 1991 (Mata leu2 u r d  trpl prb1-1122pep4) or BJ405 (Mata  trpl 
prbl prcl pep4-3). The plasmid pARS1.4.1 has been previously de- 
scribed (11). This plasmid contains ARSl sequences from the RsaI 
site at nucleotide 927 to  the HinfI  site a t  nucleotide 734 (12) blunt- 
ended and cloned into the  SmaI site of pUC19 such that domain A 
of ARSl (13) lies on the EcoRI side of the polylinker and domain B 
(13) lies on the Hind111 side of the polylinker. As previously noted 
( l l ) ,  this places domain B of ARSl between the BamHI  site of the 
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pUC19 polylinker and the internal BgnI site (12). Domain B was 
then sequentially reiterated to yield the plasmid pARS1.4.16, con- 
taining 16 head-to-tail copies of domain B (see Fig. 4A) by a previ- 
ously described method (14, 15). pARS2 contains the 627-bp XhoI 
fragment from ARS2 (16) derived from the plasmid YRpl4/CEN4/ 
ARS2 (17) cloned into  the SalI site of pUC119. pUC118/2 pM ori 
contains  the 260-bp XmnI-Ssp1 fragment containing the 2 p M  origin 
of  DNA replication (18) cloned into  the SmaI site of pUC118 such 
that  the Ssp1 site lies on the Hind111 side and  the XmnI  site lies on 
the EcoRI side of the polylinker. The plasmid pC2G1 was derived 
from C2Gl-S200, a gift from Virginia Van Houten and Carol Newlon 
(University of Medicine and Dentistry of  New Jersey), which contains 
the C2G1  200-bp  ARS (19, 20) cloned into M13  mp18. The EcoRI- 
Hind111 fragment from this M13  was subcloned into  the polylinker 
of pUC119. Note that  the C2G1 ARS is now called ARS  307. 
Purification of ABF2-Yeast was grown in YPD in a 10-liter 
fermenter to late log phase yielding approximately 700 g of wet  weight 
of  cell paste containing approximately 7.8 X 10" cells. The prepara- 
tion of yeast extracts, heparin-agarose, and Blue-Sepharose CL-4B 
chromatography of ABFl  and ABF2 have been previously described 
(11). The ABFZ activity was assayed by a DNA binding assay using 
ARSl DNA as described below.  ABFZ was eluted from Blue-Sepha- 
rose in 50 mM Pipes, pH 6.5, 10 mM sodium metabisulfite, 1 mM 
phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM dithiothreitol, 
40% ethylene glycol, 2.5 M NaCI, and loaded directly onto  a 30-ml 
column of phenyl-Sepharose (Pharmacia  LKB Biotechnology Inc.) 
equilibrated in buffer X [50 mM Pipes, 10 mM sodium metabisulfite, 
1 mM phenylmethylsulfonyl fluoride, 10 mM dithiothreitol, 1 mM 
EDTA, 20% (v/v) glycerol, final pH 6.51 containing 2.5 M NaCl. The 
column was washed successively with 3 column volumes each of 
buffer X containing 0.5 M NaCl and buffer X without NaC1. ABFZ 
was eluted from the column with buffer X containing 5%  Triton X- 
100. This fraction was concentrated by loading it directly onto a 10- 
ml column of heparin-agarose equilibrated in buffer X and eluting 
ABF2 with buffer X containing 2 M NaC1. The concentrated ABF2 
was loaded directly onto a Sephacryl S-200 column (2 X 100 cm) 
equilibrated in buffer X containing 0.5 M NaCl. Active fractions were 
dialyzed against buffer X containing 0.3 M NaC1, diluted to 0.1 M 
NaCl with buffer X and loaded onto a Mono S HR 5/5 column 
equilibrated in buffer X containing 0.1 M NaCl. The column was 
developed with a  5-ml gradient from 0.1 to 0.6 M NaCl in buffer X. 
Active fractions were  pooled and stored at -70 "C. 
One such preparation yielded 1.6 mg  of purified ABF2.  ABF2  DNA 
binding activity cannot be quantified in crude extracts due to  the fact 
that substantial  amounts of competitor DNA are required to see the 
ABF2 specific signal which, nonetheless, inhibit ABFZ binding sub- 
stantially. However, an estimate of recovery can be made as follows: 
1.6 mg of a 20-kDa protein corresponds to approximately 4.6 X 10l6 
molecules. Since there  are approximately 250,000 molecules of  ABFZ 
per cell (see below), there were 250,000 X 7.8 X 10" or 1.95 X 1017 
molecules of  ABFZ in the  starting cell mass. Therefore, the recovery 
in this purification was approximately 4.6 X 1016/1.95 X 1017 = 0.236 
or 23.6%. It should be noted that, because of the dual subcellular 
location of ABF2, it is not possible at  this point to know whether 
both sources are represented in the purified protein or if one pool is 
preferentially extracted  under the conditions used for this prepara- 
tion. 
DNA Binding and Competitions-DNA fragments were 5'-end- 
labeled with [y-32P]ATP by standard procedures (21). DNA binding 
reactions for band-shift assays and DNase1 footprinting were essen- 
tially as described (11). The  standard competitor DNA used in binding 
reactions was a mixture of poly(dA)-oligo(dT) and poly(dC)-oligo(dG) 
prepared  in 10 mM Tris-HC1, pH 7.5, and 200 mM KC1 as previously 
described (15). Other competitor DNAs were prepared as follows: 
poly[d(A.T)], poly(dA) and poly(dT) were dissolved at 1 mM nucleo- 
tide and treated the same as the other  synthetic DNAs (15). Hybrid- 
ization of equimolar amounts of poly(dA) and poly(dT) was as de- 
scribed for other synthetic DNAs (15) to yield poly(dA)-poly(dT). 
Plasmid DNAs were purified by alkaline lysis and CsCl gradients 
(21) and, where indicated, digested with restriction enzymes according 
to  the manufacturer's instructions. 
Supercoiling Reactions-Plasmid DNA (10 pg) was relaxed with 
empirically determined amounts of calf thymus topoisomerase I in 50 
mM Tris-HC1, pH 7.5, 10 mM MgCL,  0.5 mM dithiothreitol, 0.5 mM 
EDTA, and 0.03 mg/ml BSA in 100 pl at 30 "C for 60 min. The 
relaxed plasmid was extracted once with phenol and once with 24:l 
ch1oroform:isoamyl alcohol, precipitated with ethanol and resus- 
pended at a concentration of 1 mg/ml. Relaxed plasmid was incubated 
with the indicated amounts of  ABFS under the  standard DNA binding 
conditions for 30 min at 30 "C in the presence of an empirically 
determined large excess of calf thymus topoisomerase I. Reactions 
were then terminated by adding an equal volume  (10  pl) of 0.2 mg/ 
ml proteinase K, 20 mM EDTA, and 2% SDS. After 30 min at  37 "C, 
1 pg  of E. coli tRNA was added and reactions were diluted with water 
and NaCl to 100 pl, 0.1 M NaCl and precipitated with ethanol. 
Samples were resuspended in 10 mM Tris,  pH 7.4,1 mM EDTA (TE) 
and subjected to electrophoresis in 1% agarose gels in Tris-Borate 
EDTA (21) buffer containing the indicated amounts of chloroquine. 
RESULTS 
Purification of ABF2"ABFl  and ABFZ were initially de- 
scribed as proteins from whole cell yeast extracts  that  inter- 
acted specifically with  a labeled DNA probe containing the 
yeast origin of chromosomal DNA replication, ARS1, in a 
band-shift assay (11). We have used this assay to follow these 
binding activities  during their purification. Our purification 
of ABFl  has been previously described (ll),   and in this report 
we describe the purification and characterization of  ABF2. 
ABFl  and ABFB eluted  together from heparin-agarose at  
approximately 300 mM (NH&S04  and were separated from 
each other on agarose columns containing the blue dye Ciba- 
cron Blue 3GA. ABFS bound extremely tightly to  this dye 
column, requiring at  least 1.5 M NaCl for elution. Subsequent 
experiments showed that dye binding was competitive with 
DNA binding, suggesting that  the dye and DNA interact with 
the same site on the protein (data not shown). ABFZ was 
subsequently purified through a series of chromatographic 
steps (see "Materials and Methods") culminating  in  a Mono 
S FPLC column. The DNA binding activity and polypeptide 
profile eluting from one such Mono S column is shown in Fig. 
1, A and B. A polypeptide of 20 kDa coeluted with DNA 
binding activity from this column as well as several other 
columns (data  not shown). This,  taken with the fact that  this 
20-kDa polypeptide was absent from strains in which the 
ABF2  gene has been deleted (5), indicate that it is ABFB. 
To carefully quantify the amount of  ABFB per cell, immu- 
noblots were performed. Cells grown to mid-log phase in 
medium containing either glucose (YPD) or glycerol (YPG) 
as  the sole carbon source was counted, and extracts from lo7 
cells were made by disruption with glass beads to nearly 100% 
lysis. Lysed cells were boiled in SDS sample buffer to  insure 
that all of the cellular ABFS  was extracted.  Different amounts 
of these extracts were subjected to electrophoresis alongside 
different amounts of purified ABF2, proteins were transferred 
to nitrocellulose, and blots were probed with anti-ABF2 an- 
tibody. The results  in Fig. 1C reveal several features. First, 
cells grown in either glucose or glycerol have virtually iden- 
tical amounts of ABF2. Thus, ABFB levels are  not  dictated 
by mitochondrial activity or  total  amounts of mitochondrial 
DNA, which increase when cells are grown on  a  nonferment- 
able carbon source such as glycerol.  And second, the amount 
of ABF2 per cell can be estimated  quite accurately by com- 
paring the  amount of immunoreactive material from a given 
number of cells with the  standards. 300,000 cells (e.g.  lunes 3 
and 6) contains approximately the same  amount of immuno- 
reactive material at  20 kDa as does 2.5 ng of purified ABFZ 
( l a n e  7). Given a molecular weight of approximately 20 kDa, 
this corresponds to 1.25 X mol or 7.5 X 10" molecules 
and, therefore,  represents 250,000 molecules of  ABFB per cell. 
Since haploid yeast cells contain approximately 50 molecules 
of mtDNA of approximately 75,000 bp each (34), there are 50 
X 75,000/250,000, or 15 bp of mtDNA per molecule of  ABF2. 
We note that  this estimate of the amount of ABF2 per cell is 
in agreement with that of Caron et al. (25) for the  HM protein. 
Relative  Affinity of ABF2  for DNA  Sequences-Early in our 
analysis, we realized that ABFZ would bind many labeled 
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FIG. 1. Mono S chromatography of ABFS. A ,  DNA binding 
activity. ABF2  was purified as described under  “Materials and Meth- 
ods.” 0.10 pl of the indicated fractions from the Mono S HR 5/5 
column was assayed for DNA binding activity as described under 
“Materials and Methods.” B, SDS-polyacrylamide gel electrophoresis. 
10 pl of the same fractions were subjected to electrophoresis through 
a 15% SDS-polyacrylamide gel as described. The gel was stained with 
0.1% Coomassie Brilliant Blue R-250 in 50% methanol,  10% acetic 
acid and destained in 5% methanol, 7.5% acetic acid. The  apparent 
molecular weights of the marker proteins are indicated. C, quantita- 
tion of intracellular ABF2  levels. BJ405 was  grown to mid-log phase 
(approximately 1.5 X lo’ cells/ml) in  either  YPD (lanes 1-3) or YPG 
(lunes 4-6). 1 X lo7 cells were harvested by centrifugation, washed, 
and lysed by disruption with glass beads in 0.1 ml of SDS sample 
buffer and boiled for 5 min. Cell debris was removed by centrifugation 
and 1 11, corresponding to 1 X lo5 cells (lunes 1 and 4 ) ,  3 pl, 
corresponding to 3 x 10“ cells (lanes 2 and 5) and 10 pl, corresponding 
to  1 X IO6 cells (lanes 3 and 6 )  were subjected to electrophoresis in 
15% SDS-polyacrylamide gels alongside 2.5, 7.5, 22.5, 67.5, 202.5 ng 
of purified ABF2 (lanes 7-11, respectively). The gel was electroblotted 
and probed with anti-ABF2 antibody  as described (5).  The second 
antibody used in these experiments was horseradish peroxidase- 
conjugated goat anti-rabbit. 
DNA fragments in a band-shift assay. Its binding to ARS1- 
containing DNA fragments, however, was qualitatively  quite 
different. Examples of band  shifts  are shown in Fig. 2  with 
labeled DNA fragments  containing only pBR322 DNA (two 
different fragments, Fig. 2, A and C) or only ARSl DNA (two 
different fragments, Fig. 2, B and D ) .  Each probe produced 
multiply shifted bands with increasing amounts of ABF2. 
Furthermore, for all of the probes tested, successively slower- 
migrating  bands  appeared at  the  same ABF2 concentration, 
suggesting that ABF2 had roughly the  same affinity for each 
DNA fragment. 
This last point was emphasized by competition analysis 
with  different  linear plasmids. Fig. 3 shows that  both pUC19 
and pARS1.4.1 (pUC19 containing  domains  A and B of ARSl 
inserted in  the polylinker (11) were equally effective as com- 
petitors for ABFB bound to  either  ARSl DNA or pBR322 
DNA. From these  and  other experiments we conclude that 
ABFS has a  similar  affinity for most DNA (although, see Fig. 
7). 
DNA Bending byABF2”The  band-shift  patterns produced 
with the different  probes in Fig. 2 were strikingly different; 
two different pBR322 probes  each produced an orderly ladder 
A B C D 
FIG. 2. Band-shift pattern with ARS and non-ARS DNA. 
The indicated amounts of purified ABFS  were incubated in standard 
DNA binding assays with 5”end-labeled DNA. The probes used in 
this experiment were A, the BamHI-SaZI fragment from pBR322; B, 
the EcoRI-Hind111 fragment from pARS1.4.1 containing nucleotides 
734-927  of ARSl (11, 12); C, the EcoRI-BarnHI fragment from 
pBR322; and D, the EcoRI-Hind111 fragment from pARS1.2 contain- 
ing nucleotides 616-927  of ARSl (11, 12). The position of unbound 
DNA with each fragment is seen in the lanes  without added ABF2. 
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FIG. 3. Plasmid competitions. 1 pg of purified ABFB was incu- 
bated with 20,000 cpm of labeled probe from either pBR322 (BarnHI- 
Sal1 fragment) or ARSl (EcoRI-Hind111 fragment from pARSl.4.1- 
see “Materials and Methods”)  in the presence of the indicated 
amounts of the indicated plasmid competitors prior to band-shift 
analysis. Plasmid competitors were first linearized with EcoRI, puri- 
fied by extraction with phenol and 24:l ch1oroform:isoamyl alcohol, 
and precipitated with ethanol. 
of shifted bands with  increasing amounts of protein, while the 
two ARSl probes produced a more complex pattern of shifted 
bands. The relative positions of these shifted bands in the 
case of ARSl was dependent upon where ARSl lies within 
the fragment, suggesting that ABF2 causes the induction of 
specific bends a t  ARS1. 
Preliminary band shifts with different regions of ARSl 
suggested that domain  B was primarily responsible for this 
anomalous behavior (data not shown). Therefore, we con- 
structed a  plasmid  in which domain  B was reiterated  in head- 
to-tail  fashion 16 times. From this plasmid, DNA fragments 
of identical size can be excised using different restriction 
enzymes that each  normally cut  just once within domain B. 
Each of these excised fragments,  therefore, contain different 
circular permutations of the identical sequence. This strategy 
is outlined  in Fig. 44. 
These fragments were then 5’-end-labeled with 32P and 
used in  band-shift  assays  with  different amounts of purified 
ABFB (Fig. 4B). Although the molecular weight of each frag- 
ment was identical, the relative mobility of these  fragments 
without added protein was slightly  different because of a static 
bend within domain B of ARSl (22). Because the relative 
mobility of bend DNA is dependent upon the position of the 
bend within the fragment, we could infer the effect of  ABFB 
on  bending by examining the relative  positions of the  band 
shifts produced by the binding of one, two, three etc. molecules 
of ABF2. For example, although the P and H fragments 
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FIG. 4. ARSl bending by ABFl. The plasmid pARS1.4.16, 
containing 16 head-to-tail copies of  domain B (thick block line) (13) 
was constructed as described  under  "Materials  and  Methods"  and is 
shown, in part, in A. The striped box is domain  A (13) and the dotted 
line  represents the vector  sequence. For the purpose  of illustration, 
only two complete  and  two  partial copies (interrupted by wavy lines) 
of domain  B  are  shown.  Fragments excised with Sau3A (S), HgiAI 
( H ) ,  and PstI (P) all contain identical, circularly permuted DNA 
sequence. These fragments were 5'-end-labeled and used in band- 
shift assays with the indicated amounts of ABFZ ( B ) .  Different 
complexes formed with increasing amounts of  ABF2,  which  are  re- 
ferred to in the text, are designated by number at the right of the 
figure  along with the position of  unbound DNA, designated U. 
migrated together in  the absence of ABF2, the first band- 
shifted product with ABFZ (designated 1 in Fig. 4B and 
presumably representing a monomer of ABF2 bound) caused 
the P fragment to migrate slower than  the H fragment. This 
indicated that  the ABF2-induced bend center in this complex 
was different from that in the naked DNA fragment. Another 
transition in bend center could  be seen between the 1 and 2 
complexes, at which point the P fragment became the slowest 
migrating fragment. Again, in  the 3 complex, the H fragment 
became the slowest migrating fragment. The results presented 
in Figs. 2 and 4 indicate that ABFZ induces a specific and 
complex pattern of  DNA bending at  ARS1. 
Specific, Phased Binding of ABF2"The specific pattern of 
DNA bending demonstrated in Figs. 2 and 4 implied that 
ABFZ must be binding nonrandomly across DNA fragments 
containing ARS1. Data presented in Figs. 2 and 3, however, 
suggested that the overall affinity of ABF2 for ARS1- and 
pBR322-containing DNA fragments was  roughly  equal. 
To resolve this  apparent paradox, we have  analyzed ABF2 
binding to various DNA  molecules  by DNasel footprinting. 
Using DNA fragments for pBR322 as labeled probe, high 
ABFZ concentrations protected virtually the  entire fragment 
from DNasel digestion  (Fig.  5A). We interpret this result as 
indicating that ABFZ could bind at  multiple random locations 
across this fragment. At high ABF2 concentrations, each 
molecule was essentially coated with ABF2, however, the 
register of  ABFZ binding on each fragment was random. Thus, 
the entire population produces what appears to be random 
protection which we term "unphased"  binding. 
In contrast, DNasel footprints at ARSl (Fig. 5B)  as well 
as several other nuclear ARS elements including ARS2  (Fig. 
5C) (16), the C2G1 ARS (ARS307, Fig. 5 0 )  (20) and  the 2 
pM origin of  DNA replication (Fig. 5 E )  (18) as well as 
regulatory sequences from the yeast mitochondrial genome 
(5) were distinctly nonrandom. In each case, even at  the 
highest ABFB concentrations, multiple, very  clearly  defined 
regions of DNasel protection of between 25 and 30  bp  could 
be discerned, separated by  very short regions of absolutely  no 
protection, often containing distinct  DNasel hypersensitive 
sites. Thus, with these DNA fragments, ABF2 binding on 
virtually every molecule in the population occurred at the 
same site(s). We term  this mode  of binding as being  "phased." 
The  data presented in Figs. 2,3 and 5 indicate that phased 
binding could not be due to higher affinity of  ABFB for  specific 
sites within ARS1. A clue to understanding how phased 
binding occurred  could be found  by  looking at the sequences 
in and around the phased binding sites. We noticed that, 
although we could find no consensus sequence within the 
footprinted regions, in nearly all cases, the 11-bp ARS con- 
sensus sequence (A/TT"ATPuTTTA/T) and near matches 
of this sequence (9/11 and 10/11 matches) were found at the 
borders of the phased sites (Fig. 6, A-0). This suggested that 
phased binding may be accomplished by the exclusion of 
ABF2 from these A+T-rich sequences. The most striking 
example of this was seen with the mitochondrial sequence 
p64. This sequence is a 64-bp multiple direct repeat derived 
from the REP2 origin of mitochondrial DNA replication 
containing only A and T residues (23). Most of this sequence, 
consisting primarily of alternating A and T residues,  is  found 
entirely within the phased binding sites. The sequence de- 
viates from alternating A and T residues at  the borders of the 
phased binding sites, where a stretch of 9 of 11 T residues  in 
one strand is found (Fig. 6E). 
To test the hypothesis that phased binding is due to exclu- 
sion of  ABF2  by stretches of poly(dA) [or poly(dT)], we have 
looked at  the ability of synthetic and  natural DNA  molecules 
to act as competitors for ABF2 binding to labeled DNA 
fragments containing ARS1. In  this experiment, increasing 
amounts of linear pUC19  (Fig.  7A), the alternating copolymer, 
poly[d(A.T)] (Fig. 7B), and the double-stranded homopoly- 
mer,  poly(dA) .poly(dT) (Fig.  7C)  were  used as competitors in 
band shifts using subsaturating amounts of  ABF2. It is  clear 
from this experiment that while both pUC19 and poly[d(A. 
T)] were effective competitors, poly(dA) .poly(dT) was  com- 
pletely ineffective. 
Thus, we conclude that ABF2 is unable to bind to stretches 
of poly(dA) in duplex DNA and that  the phased location of 
even  very short stretches of poly(dA) at approximately 25- 
30-bp intervals is  probably  responsible for the phased binding 
seen at  nuclear and mitochondrial regulatory sequences. 
Negatiue Supercoiling by ABF2-A common feature of 
many abundant, small DNA binding proteins including 
HMGl is the ability to induce the formation of supercoils in 
relaxed,  closed circular plasmid  molecules in cooperation  with 
topoisomerase I. This reflects the fact that, in binding, these 
proteins induce a superturn in the DNA  molecule,  presumably 
by constraining a superturn of the opposite  modality  (wrap- 
ping).  Topoisomerase then removes the unconstrained super- 
turn, altering the linking number in the closed  circle  which, 
upon deproteinization, can be  visualized  by  agarose  gel  elec- 
trophoresis. 
We tested  the ability of  ABF2 to induce  supercoiling under 
such conditions. Fig. 8A shows that increasing amounts of 
ABFB in the presence of a constant amount of  calf thymus 
topoisomerase I generated increasing amounts of a product 
that comigrated with form  I-supercoiled  plasmid DNA. Al- 
though the plasmid used in this experiment contained ARS1, 
the presence of ARS sequences or, in fact, any yeast se- 
quences,  was not required  for  supercoiling (data not shown) 
consistent with our finding that ABFZ binds efficiently to 
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FIG. 5. DNasel footprints with 
ABFP. DNasel footprints were per- 
formed with purified ABF2 essentially as 
described (11). Reactions contained 32P- 
5'-end-labeled DNA probes as follows: 
A,  the BamHI-Sal1 fragment from 
pBR322 labeled at  the Sal1 site; B, the 
EcoRI-Hind111 fragment from pARS1.2 
labeled at  the EcoRI site; C, the EcoRI- 
HindIII fragment from pARS2 labeled at  
the HindIII site; D, the EcoRI-Hind111 
fragment from pC2G1 labeled at the 
EcoRI site; and E, the EcoRI-Hind111 
fragment from pUC118/2 pM origin la- 
beled,at  the HindIII site. For B-E reac- 
tions in lanes 1-5 contained 0,0.03,0.06, 
0.09, and 0 pg  of purified ABF2. For A ,  
reactions  in lanes 1-4 contained 0, 0.05, 
0.1, and 0 pg of purified ABF2. 
A ABF I . 
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FIG. 6. Summary of DNasel footprints. The positions of the 
ABF2 footprints shown in Fig. 5 (A-D)  and by Diffley and Stillman, 
1991 (5) ( E )  are indicated as stippled boxes. Numbers within the boxes 
correspond to  the numbers in the right margins of Fig. 5. The 11-bp 
ARS consensus sequence at  each ARS is shown as striped boxes 
indicated as "11" while near  matches to  this sequence are shown as 
black  boxes designated "9" for 9/11 matches and "10" for 10/11 
matches. The position of domains A and B (13) of ARSl  are indicated 
in A as is the position of the  ABFl binding site (11, 41). DNasel 
hypersensitive sites are indicated by arrows. In E, greater resolution 
of the footprinted region is shown. In  this panel, the maximum and 
minimum extents of the footprints  are shown as  short  and tall boxes, 
respectively, to indicate uncertainties a t  bases which are  not cleaved 
efficiently by DNasel.  The bracketed 5a region in E represents the 
smallest reiterated sequence (35 bp) found by Fangman and co- 
workers (23) to be replicated in yeast mitochondria. Note that  this 
corresponds very closely to a single ABF2 footprint. The boxed 
sequence represents  a stretch of 9/11 T residues discussed in the text. 
vector sequences (Fig.  2, 3, and 5). 
To determine the direction of the supercoiling induced by 
ABF2, aliquots of the reaction products shown in Fig. 8A were 
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FIG. 7. Competitions with synthetic DNAs. 0.5 pg of purified 
ABFB was incubated with 20,000 cpm of labeled ARSl probe (EcoRI- 
HindIII pARS1.4.1) in the presence of the indicated amounts of the 
different linear competitor DNAs. DNA-protein complexes were vis- 
ualized as described under  "Materials and Methods." The competitor 
DNAs were: A ,  EcoRI-digestedpUC11S; B, poly[d(A.T)]; C, poly(d.4)- 
P o W T ) .  
subjected to electrophoresis through agarose gels containing 
different amounts of chloroquine. Chloroquine intercalates 
into DNA and unwinds it, introducing positive superhelical 
twists  into covalently closed  DNA. Therefore, with increasing 
concentrations of chloroquine, negatively supercoiled DNA 
will transiently  appear to relax, and  then become supercoiled 
again (positively), while positively supercoiled DNA will be 
unaffected by any  concentration of chloroquine. The results 
of this experiment are shown in Fig. 8, B and C. From this 
experiment, it is evident, particularly at  intermediate concen- 
trations of ABF2, that  the supercoiled product appeared to be 
relaxed by  low concentrations of chloroquine. Therefore, we 
conclude that ABFB induces the formation of negatively su- 
percoiled DNA in this assay. 
In addition to inducing the formation of negatively super- 
coiled  DNA, competition analysis has shown that ABFP 
bound approximately 10 times more tightly to negatively 
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FIG. 8. Negative supercoiling by ABFB in the presence of 
topoisomerase I. The indicated amounts of purified ABF2 were 
incubated with relaxed pARS1.1 in the presence of excess calf thymus 
topoisomerase I and processed for electrophoresis as described under 
“Materials and Methods.” 1% agarose gels and gel running buffer 
contained 0 ( A ) ,  1 ( B ) ,  or 3 ( C )  p~ chloroquine. The relevant  controls 
in  this experiment are  M (HirzdIII-digested adenovirus type 2 DNA), 
Sc (unrelaxed, negatively supercoiled pARS1.1) and the reaction 
containing no ABF2 (0). 
A B 
COMPETITOR PARS 14.1 PARS 1.4.1 
LINEAR SUPERCOILED 
- m u  bjl -dull 
FIG. 9. Plasmid competitions with linear and supercoiled 
plasmid DNA. The indicated amounts of either EcoRI-linearized or 
supercoiled pARS1.4.1 were used as competitor DNA in binding 
reactions containing 1 pg of purified ABF2. The probe used in this 
experiment is the EcoRI-Hind111 fragment from pARS1.2 and DNA- 
protein complexes  were visualized as above. 
supercoiled DNA (Fig. 9B)  than  to linear (Fig. 9A) or relaxed 
closed circular DNA (data not shown). 
DISCUSSION 
ABF2 as the Mitochondrial DNA Packaging Protein-Sev- 
era1 lines of evidence argue that ABFB is an  important  struc- 
tural element of the yeast  mitochondrial nucleoid. 
First, ABF2 is an extremely abundant protein. There  are 
approximately 250,000  ABFB molecules in each  yeast cell, at  
least half of which reside in  the mitochondria. Thus, even if 
only half of the intracellular ABFB is mitochondrial, there is 
one ABF2 molecule for every 30 bp of mitochondrial DNA 
assuming that ABF2 binds as a monomer. Indeed, it exists  in 
solution as a monomer. Since 25-30 bp of DNA are protected 
in each of the phased  footprints, this suggests that  there is 
enough ABFB to coat all of the mitochondrial DNA. Second, 
although ABFB null mutants can be maintained on  nonfer- 
mentable carbon sources, they grow quite poorly and lose 
their mitochondrial DNA at  an extremely high rate, suggest- 
ing a dysfunction in  mitochondrial DNA metabolism. Third, 
as shown in Fig. 8, ABF2 can induce the formation of negative 
supercoils in DNA in cooperation with DNA topoisomerase. 
Both  the eucaryotic nucleosome and  the E. coli HU  protein 
exhibit  a  similar activity. In  the case of the nucleosome and 
probably the HU protein  (although, see Ref. 24), supercoiling 
is generated by DNA wrapping around  a central  protein core. 
Therefore, ABFZ, at  least potentially, has one of the most 
important activities of packaging proteins: the ability to com- 
pact  the DNA molecule. A previously described protein, HM, 
has some properties that  are related to ABF2 and may, in 
fact, be the  same protein  (25). 
We note that ABF2 is a close relative of the vertebrate 
HMGl protein, and it has been long known that HMGl 
proteins exhibit  a  similar supercoiling activity. Based primar- 
ily on thermal  denaturation studies (26,27)  and  the ability of 
HMGl to bind single-stranded DNA (29, 29), it has been 
concluded that  this supercoiling activity is not due to wrap- 
ping, but  rather,  to DNA unwinding by HMG1. We believe 
that,  at least with ABF2, this is not  the case primarily because 
ABFB does not bind well to single-stranded DNA either  in 
the band-shift or competition  assays (data  not shown). 
Dunaway (30) has shown that  the RNA polymerase I tran- 
scription factor TFIS, also known at UBF, appears to wrap 
DNA in its binding to the promoter and enhancer of the 
rRNA gene based, not on the supercoiling assay, but on the 
periodicity of DNase1 cleavage sites. UBF  has been cloned 
and sequenced and shown to contain at  least three HMG 
boxes (31) suggesting that DNA wrapping may  be a general 
property of HMG1-related  proteins. 
ABF2 in Mitochondrial Transcription and Replication- 
Specific trans-acting factors involved in transcription and 
replication must somehow gain access to key regulatory se- 
quences despite the presence of large amounts of abundant, 
nonspecific packaging proteins. The DNA-binding properties 
of ABF2 may provide a mechanism whereby most of the 
mitochondrial DNA can be packaged by  ABF2 without inter- 
fering with the binding of these key regulatory proteins. We 
have demonstrated  that ABFZ can be specifically excluded 
from binding to certain simple DNA sequences [poly(dA)] 
and have provided evidence that very short runs of this 
sequence, as few as 9/11  A residues, can exclude ABF2 bind- 
ing. When these short sequences are phased at  25-30 bp 
intervals, we suggest that ABF2 binding becomes phased by 
virtue of this exclusion phenomenon.  Furthermore, we suggest 
that ABFB binding  requires  a region of at  least 25 bp free of 
these exclusion sequences and that if these exclusion se- 
quences occur more frequently than once every 25 bp, large 
regions of DNA can exclude ABF2 binding. Footprints on 
REP2, a  putative replication origin from the mitochondrial 
DNA demonstrate that long DNA sequences can exclude 
ABF2 binding (5). 
In fact,  within REP2,  there  are only two regions of signifi- 
cant ABFB binding. One of these is the sequence from which 
p64  was derived, which can presumably  function as a  minimal 
replication origin, and  the  other is a single site immediately 
adjacent to  the promoter for the mitochondrial RNA polym- 
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erase (32). This is probably not coincidental as Parisi and 
Clayton (8) have recently shown that  the activator of mito- 
chondrial  transcription in uitro, mtTF1, is similar to ABFP. 
Human mtTF1, which is also related to HMG1, binds to 
promoters  present  in human  and murine mtDNA and  acti- 
vates transcription. In  the accompanying paper,  Fisher et al. 
(10) show that mtTFl from human cell mitochondria has 
similar DNA binding properties as ABF2. Thus, in  addition 
to being a structural component of the mitochondrial nu- 
cleoid, ABFS may also be an activator of transcription  and 
replication. We note  in this regard, the recent identification 
of  HMGl and/or  2 as a  candidate for the general transcription 
factor  IIB (33). 
ABF2 in the Nucleus-Subtleties in the distribution of 
ABF2 within the cell remain unclear. Both indirect immu- 
nofluorescence and subcellular fractionation agree that a large 
fraction of ABF2 is mitochondrial (5). This fact is also sup- 
ported by the phenotype of abf2- null mutants. By indirect 
immunofluorescence, however,  ABF2  was not detected  in the 
nucleus, while by subcellular fractionation, at  least half of the 
intracellular ABF2 cofractionated with nuclei. This was not 
due to contamination of the nuclear fraction with mitochon- 
dria, as p32, a mitochondrial integral membrane protein (34) 
was absent in these fractions (5). We cannot exclude the 
possibility that  the nuclear ABF2 was due to leakage out of 
the mitochondria and  into  the nuclei, however, we consider 
this unlikely since, in the same  experiments, there was vir- 
tually  no ABFS in  the cytosolic fraction. Thus, at  present, we 
believe that some ABF2  may  be present  in the nucleus in  a 
form that is inaccessible to  the antibody  in the immunofluo- 
rescence experiments, although we cannot exclude the possi- 
bility that  the nuclear localization may  be an  artifact of the 
subcellular fractionation. 
We have not been able to detect any deficiencies in the 
abf2- null mutants  that  cannot be explained by its role in 
mitochondrial genome function. Its presence in the mitochon- 
dria, together with the finding that  the possible human hom- 
ologue of  ABF2 is a specific factor for in vitro mitochondrial 
transcription argue that  at  least  part of the function of ABF2 
is executed in the mitochondria. 
None of this, however, excludes the possibility that ABF2 
executes some of its functions in  the nucleus. It is, for exam- 
ple, tempting to speculate that nuclear localization of ABF2 
may function as part of a feedback mechanism whereby the 
nucleus can monitor the  amount of mitochondrial DNA and 
regulate the expression of the mitochondrial replication ma- 
chinery accordingly. In  this regard, we note that various p- 
mutants of yeast, in which gross alterations in  and deletions 
of the mitochondrial genome have occurred, all have approx- 
imately the same overall amount of mitochondrial DNA (35, 
36), as if the nucleus monitors the  total amount of mitochon- 
drial DNA rather  than  the levels of specific sequences within 
the genome. Furthermore, we note that the mitochondrial 
genotype ( p + ,  p-, po, or mit-)  can alter  the level of transcription 
of several nuclear genes (37). 
If  ABF2 has  any  function  in the nucleus outside of its role 
in maintaining the mitochondrial genome, that function  must 
either be dispensable or redundant with another gene product. 
A true homologue of the vertebrate HMGl  has  not yet been 
identified in yeast, although several genes with regions of 
HMGl homology have been identified (38-40). It will be 
interesting to see if any of these nuclear proteins  exhibits the 
same phased binding to nuclear ARSs. 
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